NanoViricides
NNVC
40 hedge funds and large institutions have $630K invested in NanoViricides in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0.05% less ownership
Funds ownership: 0.3% → 0.25% (-0.05%)
7% less funds holding
Funds holding: 43 → 40 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
54% less capital invested
Capital invested by funds: $1.36M → $630K (-$727K)
Top Buyers
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$13.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.09K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$7.78K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$4.67K |
| 5 |
Millennium Management
New York
|
+$4.27K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$160K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$42.4K |
| 3 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
-$18K |
| 4 |
Renaissance Technologies
New York
|
-$10.5K |
| 5 |
Goldman Sachs
New York
|
-$5K |
NNVC Hedge Fund Activity: Q4 2018 in Review
40 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q4 2018, worth a combined $630K — down 54% from $1.36M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of NNVC and 4 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 6 added.
The largest buyer was Panagora Asset Management, opening a new position worth an estimated $13.4K. The largest seller was Vanguard Group, cutting an estimated $160K.
- 40 institutional investors held NanoViricides (NNVC) as of Q4 2018, down from 43 in Q3 2018.
- Funds reported $630K of NanoViricides stock for Q4 2018, down 54% quarter-over-quarter.
- 4 funds opened new NanoViricides positions in Q4 2018 and 7 closed out, a net change of -3 holders.
- The largest NanoViricides buyer in Q4 2018 was Panagora Asset Management, an estimated $13.4K added.
- The largest NanoViricides seller in Q4 2018 was Vanguard Group, an estimated $160K sold.
Based on aggregated 13F filings for Q4 2018.